CA3029032C — Crystalline salts of peptide epoxyketone immunoproteasome inhibitor
Assigned to Kezar Life Sciences Inc · Expires 2024-10-29 · 2y expired
What this patent protects
Provided herein is a peptide epoxyketone immunoproteasome inhibitorhaving a structure: Formula (I) wherein X- is a counterion, crystal forms, salts, and processes for making the same, and formulations thereof.
USPTO Abstract
Provided herein is a peptide epoxyketone immunoproteasome inhibitorhaving a structure: Formula (I) wherein X- is a counterion, crystal forms, salts, and processes for making the same, and formulations thereof.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.